These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 19679152)

  • 21. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery.
    Saito R; Krauze MT; Noble CO; Tamas M; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS
    J Neurosci Methods; 2006 Jun; 154(1-2):225-32. PubMed ID: 16472868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery.
    Hadinoto K; Zhu K; Tan RB
    Int J Pharm; 2007 Aug; 341(1-2):195-206. PubMed ID: 17467934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pH-sensitive Eudragit nanoparticles for mucosal drug delivery.
    Yoo JW; Giri N; Lee CH
    Int J Pharm; 2011 Jan; 403(1-2):262-7. PubMed ID: 20971177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and characterization of novel quaternized cellulose nanoparticles as protein carriers.
    Song Y; Zhou J; Li Q; Guo Y; Zhang L
    Macromol Biosci; 2009 Sep; 9(9):857-63. PubMed ID: 19370752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel solid lipid nanoparticles as carriers for oral administration of insulin.
    Zhang Z; Lv H; Zhou J
    Pharmazie; 2009 Sep; 64(9):574-8. PubMed ID: 19827297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug delivery from ordered mesoporous matrices.
    Manzano M; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1383-400. PubMed ID: 19941412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles.
    Yuan H; Jiang SP; Du YZ; Miao J; Zhang XG; Hu FQ
    Colloids Surf B Biointerfaces; 2009 May; 70(2):248-53. PubMed ID: 19185474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid delivery of drug carriers propelled and navigated by catalytic nanoshuttles.
    Kagan D; Laocharoensuk R; Zimmerman M; Clawson C; Balasubramanian S; Kang D; Bishop D; Sattayasamitsathit S; Zhang L; Wang J
    Small; 2010 Dec; 6(23):2741-7. PubMed ID: 20979242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
    Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlling drug nanoparticle formation by rapid precipitation.
    D'Addio SM; Prud'homme RK
    Adv Drug Deliv Rev; 2011 May; 63(6):417-26. PubMed ID: 21565233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functionalized gold nanoparticles for drug delivery.
    Han G; Ghosh P; Rotello VM
    Nanomedicine (Lond); 2007 Feb; 2(1):113-23. PubMed ID: 17716197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanocarriers.
    Torchilin VP
    Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S; Ray S; Thakur RS
    Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
    Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
    J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticles made from novel starch derivatives for transdermal drug delivery.
    Santander-Ortega MJ; Stauner T; Loretz B; Ortega-Vinuesa JL; Bastos-González D; Wenz G; Schaefer UF; Lehr CM
    J Control Release; 2010 Jan; 141(1):85-92. PubMed ID: 19699771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The performance of nanocarriers for transmucosal drug delivery.
    Csaba N; Garcia-Fuentes M; Alonso MJ
    Expert Opin Drug Deliv; 2006 Jul; 3(4):463-78. PubMed ID: 16822222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fabrication of solid nanoparticles for drug delivery.
    Arayne MS; Sultana N; Noor-Us-Sabah
    Pak J Pharm Sci; 2007 Jul; 20(3):251-9. PubMed ID: 17545113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles.
    Missirlis D; Kawamura R; Tirelli N; Hubbell JA
    Eur J Pharm Sci; 2006 Oct; 29(2):120-9. PubMed ID: 16904301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.